CytoDyn Inc.
CYDY
$0.2926
-$0.0034-1.15%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.75M | -7.09M | -14.25M | -19.04M | -49.84M |
| Total Depreciation and Amortization | 18.00K | 18.00K | 20.00K | 24.00K | 29.00K |
| Total Amortization of Deferred Charges | 407.00K | 473.00K | 975.00K | 1.01M | 1.65M |
| Total Other Non-Cash Items | 3.24M | 12.31M | 19.03M | 23.11M | 25.52M |
| Change in Net Operating Assets | -16.17M | -10.47M | -7.90M | -6.14M | 11.66M |
| Cash from Operations | -8.77M | -4.75M | -2.13M | -1.05M | -10.98M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 954.00K | 1.17M | 2.31M |
| Total Debt Repaid | -710.00K | -710.00K | -710.00K | -710.00K | -- |
| Issuance of Common Stock | 1.19M | 3.46M | 6.12M | 6.56M | 9.44M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 10.38M | 10.38M | 10.38M | 10.38M | -- |
| Cash from Financing | 10.85M | 13.13M | 16.74M | 17.40M | 11.75M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.09M | 8.38M | 14.61M | 16.35M | 766.00K |